Tryptophan degradation increases with stage in patients with rheumatoid arthritis
- 1 November 2005
- journal article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 25 (3), 334-337
- https://doi.org/10.1007/s10067-005-0056-6
Abstract
Immune system activation is known to be involved in the progression of rheumatoid arthritis (RA). The proinflammatory cytokine interferon-γ in various cells, including monocytes, induces the enzyme indoleamine (2,3)-dioxygenase (IDO), which converts tryptophan to kynurenine. In sera of 22 patients (17 women and 5 men) with RA stages 1 to 4 according to Steinbrocker, the concentrations of tryptophan and kynurenine were measured by high-pressure liquid chromatography. To estimate IDO activity, the kynurenine to tryptophan ratio (kyn/trp) was calculated. In parallel, concentrations of the macrophage activation marker neopterin were determined by enzyme-linked immunosorbent assay. Tryptophan concentrations were lower in patients with RA, and the decrease in serum tryptophan correlated with increase in stage (p<0.05). Kyn/trp correlated well with neopterin concentrations, which were elevated in most patients. Whereas higher C-reactive protein concentrations and erythrocyte sedimentation rates were observed in patients with greater disease activity, tryptophan and neopterin concentrations did not differ between patients with different subjective disease activity graded by the physician. Deficiency of the essential amino acid tryptophan in patients with RA most likely results from immune activation involved in the pathogenesis of the disease. It could also be relevant for the mood of patients, as tryptophan is the precursor of serotonin.Keywords
This publication has 25 references indexed in Scilit:
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999
- THE role of indoleamine 2,3‐dioxygenase in the anti‐tumour activity of human interferon‐γ in vivoInternational Journal of Cancer, 1995
- Soluble receptors for tumour necrosis factor in clinical laboratory diagnosisEuropean Journal of Haematology, 1995
- Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritisClinical Rheumatology, 1993
- Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-γBiochemical Journal, 1989
- Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effectsCellular and Molecular Life Sciences, 1989
- Serum levels of interleukin‐2 receptor and activity of rheumatic diseases characterized by immune system activationArthritis & Rheumatism, 1988
- Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritisArthritis & Rheumatism, 1988
- Urinary neopterin reflects clinical activity in patients with rheumatoid arthritisArthritis & Rheumatism, 1986
- Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.Proceedings of the National Academy of Sciences, 1984